SCHEMBL14101434

SCHEMBL14101434

c1ccc2cc(-c3ccc4ccc5c(-c6ccc7sc8ccc(-c9ccc%10ccc%11c(-c%12ccc%13ccccc%13c%12)ccc%12ccc9c%10c%12%11)cc8c7c6)ccc6ccc3c4c65)ccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.43
S1PR5 Q9H228 8/20 0.41
S1PR4 O95977 6/20 0.41
HDAC4 P56524 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
DHFR P00374 1/20 0.36
CYP1A2 P05177 3/20 0.35
ERBB2 P04626 1/20 0.35
FYN P06241 1/20 0.35
MAOA P21397 1/20 0.35
ACHE P22303 1/20 0.35
AHR P35869 1/20 0.35
ALOX5 P09917 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.34
HSD17B1 P14061 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101441 0.97 S1PR5 (0.42) GSTP1S1PR5S1PR4HDAC4HDAC2
SCHEMBL14101529 0.96 S1PR5 (0.41) GSTP1S1PR5S1PR4HDAC4HDAC2
SCHEMBL14101473 0.96 GSTP1 (0.40) GSTP1S1PR5S1PR4HDAC4HDAC2
SCHEMBL14101463 0.93 S1PR5 (0.40) GSTP1S1PR5S1PR4HDAC4HDAC2
SCHEMBL14101527 0.93 S1PR5 (0.40) GSTP1S1PR5S1PR4ESR1ESR2
SCHEMBL14101540 0.93 S1PR5 (0.40) GSTP1S1PR5S1PR4HDAC4HDAC2
SCHEMBL14101456 0.93 S1PR5 (0.40) GSTP1S1PR5S1PR4HDAC4HDAC2
SCHEMBL14101453 0.92 S1PR5 (0.38) GSTP1S1PR5S1PR4CYP1A2ERBB2
SCHEMBL14101460 0.92 S1PR5 (0.38) GSTP1S1PR5S1PR4CYP1A2ERBB2
SCHEMBL14101530 0.92 S1PR5 (0.39) GSTP1S1PR5S1PR4ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME CYBA, BPNT1, TYR GSTP1 731/4885S1PR5 4736/4885S1PR4 4464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.